Metispharmaceuticals
1 known investors
Metis Pharmaceuticals uses AI to design nanomaterials for targeted drug delivery, including molecular dynamics simulation of LNP endosomal escape. It focuses on lipid nanoparticle and nanotechnology innovation for therapeutic delivery.
AI & Machine LearningBiotechDeep Tech